| ACS | Autologous conditioned serum |
| AD-MSCs | Adipose-derived mesenchymal stem cells |
| ADSC-exo | Adipose-derived stem cell exosomes |
| AE | Adverse event |
| AGEs | Advanced glycation end products |
| AI | Artificial intelligence |
| AKT | Protein kinase B (involved in survival and growth signalling) |
| AMPK | AMP-activated protein kinase (energy-sensing enzyme) |
| AMSCs | amniotic membrane stem cells |
| ASO | Antisense oligonucleotides |
| ATM | Ataxia telangiectasia mutated (kinase activated by DNA damage) |
| Bcl-2 | B-Cell lymphoma 2 (anti-apoptotic protein) |
| BCS | Blood cell secretome |
| BET | Bromodomain and extra-terminal domain proteins |
| circRNA | circular RNAs |
| COL8A1 | collagen type VIII alpha 1 chain |
| CoQ10 | coenzyme Q10 |
| CRISPR | Clustered regularly interspaced short palindromic repeats |
| CRISPRa | CRISPR activation (gene upregulation method, without altering the DNA sequence) |
| CRISPRd | CRISPR-direct |
| CRP | C reactive protein |
| D + Q | Dasatinib + quercetin (a common senolytic drug combination) |
| DDR | DNA damage repair |
| DNA | Deoxyribonucleic acid |
| DNAm | DNA methylation (age) |
| DNMT1 | DNA methyltransferase 1 |
| DRI | D-Retro-inverso (peptide configuration for therapeutic stability) |
| ECM | Extracellular matrix |
| EGCG | Epigallocatechin-3-gallate |
| EGFR | Epidermal growth factor receptor |
| ELN | Elastin |
| EMT | Epithelial–mesenchymal transition |
| EPPK | Epidermolytic palmoplantar keratoderma |
| EV | Exosomes/extracellular vesicles |
| EWAS | Epigenome-wide association study |
| 4F | Yamanaka factors or OSKM factors: OCT4, SOX2, KLF4 and c-Myc |
| FOXO4 | Forkhead box O4 (transcription factor involved in senescence survival signalling) |
| FOXO4-DRI | FOXO4-D-retro-inverso-isoform peptide |
| GAIS | Global esthetic improvement scale |
| GLS1 | Glutaminase-1 |
| GPNMB | Glycoprotein non-metastatic melanoma protein B (senescence surface marker) |
| GWAS | Genome-wide association study |
| HaCaT | Human keratinocyte cell line |
| HACS | Human adipose tissue-derived exosome-containing solution |
| HDAC | Histone deacetylase |
| HDACi | Histone deacetylase inhibitor |
| HIF1α | Hypoxia-inducible factor 1-alpha (transcription factor in low oxygen) |
| HOTAIR | HOX transcript antisense RNA |
| HPE | Human platelet extract |
| hUC-MSCs | Human umbilical cord mesenchymal stem cells |
| HUVEC | Human umbilical vein endothelial cells |
| i.p. | Intraperitoneal |
| i.v. | Intravenous |
| IGF-1 | Insulin-like growth factor 1 |
| IIS | IGF-1 signalling pathway |
| IKK | IκB Kinase (activates NF-κB) |
| IL-6, IL-8 | Interleukin-6, interleukin-8 (pro-inflammatory cytokines, part of SASP) |
| IPL | Intense pulsed light |
| i-PRF | Injectable platelet-rich fibrin |
| iPSCs | Tissue-induced pluripotent stem cells |
| IRAK1 | Interleukin 1 receptor-associated kinase 1 |
| JAK/STAT pathway | Associated Janus kinases/ Signal transducers and activators of transcription |
| Krt9 | Keratin 9 gene |
| lncRNA | Long non-coding RNAs |
| LOX | Lysyl oxidase |
| MAE | Mean absolute error (related to skin epigenetic clocks) |
| meQTL | Epigenome-wide methylation quantitative loci |
| miRNA | microRNAs |
| ML | Machine learning |
| MMPs | Matrix metalloproteases |
| MSCs | Mesenchymal stem cells |
| mTOR | Mechanistic target of rapamycin (a central regulator of cell growth and metabolism) |
| NAD | Nicotinamide adenine dinucleotide |
| NBDS | Non-bulbar dermal sheath cells |
| ncRNA | Non-coding RNA |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells (inflammation pathway) |
| OGG1 | 8-Oxoguanine glycosylase photolyase |
| OSKM factors |
Yamanaka transcription factors or 4F: OCT4, SOX2, KLF4 and c-Myc |
| OSKMLN factors | Transcription factors OSKM + LIN28 + NANOG |
| p16Ink4A | Cyclin-dependent kinase Inhibitor 2A (senescence marker) |
| p53-pS15 | p53-Serine15 phosphorylation |
| PDGF | Platelet-derived growth factor |
| PI3K | Phosphoinositide 3-kinase (cell survival signalling pathway) |
| PKR | Protein kinase R |
| PPARα | Peroxisome proliferator-activated receptor alpha (nuclear receptor) |
| PRC2 | Polycomb Repressive Complex 2 |
| PRF | Platelet-rich fibrin |
| PRP | Platelet-rich plasma |
| PTEN | Phosphatase and TENsin (tumour suppressor gene) |
| QC | Quality control |
| RCT | Randomized controlled trial |
| Ref | Reference |
| RNA | Ribonucleic acid |
| RNase | Ribonuclease |
| ROS | Reactive oxygen species |
| SAHF | Senescence-associated heterochromatin foci |
| SASP | Senescence-associated secretory phenotype (pro-inflammatory profile of senescent cells) |
| SAβGal | Senescence-associated β-galactosidase (marker enzyme for senescent cells) |
| shRNA | Short hairpin RNA |
| SIRT | Sirtuin |
| SOCS | Suppressor of cytokine signalling |
| α--SMA | alpha-Smooth muscle actin |
| SPRY1 | Sprouty homologue 1 |
| TCA | Trichloracetic acid |
| TGF | Transforming growth factor |
| TNF | Tumour necrotic factor |
| TRAF6 | TNF receptor associated factor 6 (inflammatory signalling mediator) |
| TRF2 | Telomeric repeat binding factor 2 |
| UVB | Ultraviolet B |
| VEGF | Vascular endothelial growth factor |
| WBC | White blood cells |